3-Year Supporting Data on TAVI in Low-Risk Patients: EVOLUT

Published Date: 08 Mar 2023

3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery

Read Full News

Latest News

Transplant Recipients May Face Higher Endocarditis Mortality

Transplant recipients with infective endocarditis have a distinct microbiological profile and face a significantly higher risk for death at 1 year than non‑transplant control participants.

Medicaid Expansion May Not Curb Severe Maternal Morbidity

Medicaid expansion is linked to an increased proportion of deliveries covered but is not associated with a reduction in severe maternal morbidity during delivery hospitalization.

Certain Social Factors Tied to Metabolic Liver Disease

Food insecurity and neighborhood deprivation were each independently associated with higher incidence of MASLD, with the highest incidence among adults experiencing both.

Sports Unite Doctors in Spain and Beyond

Medical soccer, cycling, and marathon running are helping physicians build camaraderie, stay active, and strengthen professional networks beyond the hospital.

Deep Dive: Two New Drugs, One Disease: MASLD's Three-Specialty Shift

Beyond Gastroenterology: FDA Approvals and Updated Guidelines Shift Frontline MASLD Care to Primary Medicine and Endocrinology

As GLP-1s Revolutionize Obesity Care, Access Remains Uneven

GLP-1 drugs have moved rapidly into the mainstream, but recent data show that many ideal patients are still being left behind.

Todays Updates

Low Awareness of How to Spot Rare Breast Cancer Identified

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

Remote CBT for Insomnia Improves Symptoms During Chemo

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Long-Acting Interferon Therapy Approved for ET

Ropeginterferon alfa-2b is designed to provide durable disease control.

Todays Updates

Low Awareness of How to Spot Rare Breast Cancer Identified

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

Remote CBT for Insomnia Improves Symptoms During Chemo

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Long-Acting Interferon Therapy Approved for ET

Ropeginterferon alfa-2b is designed to provide durable disease control.

Latest News

Transplant recipients with infective endocarditis have a distinct microbiological profile and face a significantly higher risk for death at 1 year than non‑transplant control participants.

Medicaid expansion is linked to an increased proportion of deliveries covered but is not associated with a reduction in severe maternal morbidity during delivery hospitalization.

Food insecurity and neighborhood deprivation were each independently associated with higher incidence of MASLD, with the highest incidence among adults experiencing both.

Medical soccer, cycling, and marathon running are helping physicians build camaraderie, stay active, and strengthen professional networks beyond the hospital.

Beyond Gastroenterology: FDA Approvals and Updated Guidelines Shift Frontline MASLD Care to Primary Medicine and Endocrinology

GLP-1 drugs have moved rapidly into the mainstream, but recent data show that many ideal patients are still being left behind.

News All Time

DOACs Benefit AF Patients With Intermediate Stroke Risk

Anticoagulation reduced adverse clinical events in patients with atrial fibrillation at intermediate stroke risk, without an apparent increase in major bleeding.

Heart Failure Drug May Not Improve Exercise Fitness in nHCM

A heart failure drug combination may not improve exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy but is associated with favorable cardiac structural remodeling.

Mounjaro FDA-Approved to Reduce Cardiovascular Risk in T2D

Lilly's Mounjaro (tirzepatide) is now approved to reduce cardiovascular risk in adults with type 2 diabetes.

Weight Down, Steps Down: The GLP-1 Catch

Studies suggest that strong recommendations for exercise with GLP-1s are commonly not heeded; possible reasons vary.

Ginseng, the ‘Miracle Root’: How Strong Is the Evidence?

Evidence varies across ginseng uses, with some potential benefits but limited support for treating fatigue, cognitive decline, infections, diabetes, or cardiovascular disease.

Inpatient Weight Loss May Cut HF Rehospitalization Risk

Losing weight during hospitalization for heart failure in patients treated with intravenous loop diuretics is associated with a reduced 30-day risk for rehospitalization.

Common Lipid-Lowering Drug May Slow Diabetic Eye Damage

A common lipid-lowering drug is tied to markedly lower odds of vision-threatening retinopathy, cataracts, and macular edema in patients with mild or moderate nonproliferative diabetic retinopathy.

What Is Fibermaxxing and Is More Fiber Always Better?

Higher-fiber intake is linked to important health benefits; however, benefits appear to plateau at moderate intake, whereas excessive amounts can cause gastrointestinal symptoms.

Sleep Apnoea Tied to Heart Rhythm Risk in Dialysis Patients

Patients undergoing peritoneal dialysis who have sleep apnoea — particularly those older than 60 years — face an increased risk for new-onset atrial fibrillation, a Finnish study finds.

Diabetes Linked to Higher Risk for Sudden Cardiac Death

Diabetes may independently raise the risk for sudden cardiac death, regardless of obstructive coronary artery disease status.

‘A Lot to Say’: Doctors Use Comics to Deliver Best Medicine

From comics-style stories to New Yorker cartoons, drawing is more than a creative outlet for these doctors — they’ve helped create an impactful new field: graphic medicine.

How to Find the Sweet Spot for Cardio and Strength Training

Many people lean harder on one or the other — or do neither — but more science shows concurrent training may be the key to improved long-term health and vitality.

Overheard in Medicine: Who Owns the Incidental Finding?

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Gray-Market Retatrutide: Less Weight Loss, More CV Effects

Gray-market retatrutide use is increasing, but unapproved products aren’t delivering expected results. Its manufacturer Eli Lilly is calling for increased oversight.

Professional Corner: AMA Awards $1 Million in Grants

The AHA opens its health tech competition, AMA awards $1 million in community grants, and pediatricians call for stronger protections for children at the US border.

Preclinical Vascular Impairment Tied to Mortality

New criteria identifies preclinical vascular cognitive impairment in adults without dementia or stroke and linked it to higher cardiovascular risk and mortality.

Recommended News For You

The main subject is associated with suicide in the United States.

'Personalized' Approach to RT for Bladder Cancer Promising but Challenging

The Truth About Apple AirPods

In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.

Combination of significant weight gain and late motherhood greatly increases risk of breast cancer, study finds

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

Recommended Articles For You

Clinical Insights in Hematology in Daily Practice 

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review 

The Science Behind Thrombolytic Drugs and Their Benefits  

Digital Oncology Navigation Platforms for Coordinated Cancer Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

2.

Mezigdomide Combinations Show Promise in Multiple Myeloma

3.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

4.

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

5.

Oleanolic acid from grapes may increase chemotherapy effectiveness

1.

Advanced Approaches in Oncology and Patient Outcomes

2.

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health

3.

Emerging Advances in Hematology and Quality Improvement

4.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

5.

Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

2.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

3.

Navigating the Complexities of Ph Negative ALL - Part XIV

4.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot